Navigation Links
Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
Date:5/20/2008

SEATTLE, May 20 /PRNewswire-FirstCall/ -- Omeros Corporation today announced that it has begun patient enrollment for the Phase 1 study of OMS201, the Company's second PharmacoSurgery(TM) drug product candidate, for use during urological surgery. At least 24 patients undergoing unilateral ureteroscopic removal of stones with a maximum diameter of 12 mm located in the renal-collecting system or ureter will be enrolled in the study.

"Advancing another PharmacoSurgery(TM) product candidate into clinical development marks an important milestone for Omeros," said Dr. Gregory A. Demopulos, Chairman and Chief Executive Officer of Omeros. "From our PharmacoSurgery(TM) platform, Omeros is developing a series of product candidates to improve clinical outcomes for surgical patients. The study for OMS201 expands our PharmacoSurgery(TM) platform into urological surgery."

OMS201 is one of the four clinical development programs in the Company's PharmacoSurgery(TM) platform. PharmacoSurgery(TM) product candidates are combinations of therapeutic agents designed to act simultaneously at multiple discrete targets to preemptively block the molecular-signaling and biochemical cascade caused by surgical trauma and to provide clinical benefits both during and after surgery. The lead product candidate in the PharmacoSurgery(TM) platform is OMS103HP, which is currently in two Phase 3 clinical programs evaluating OMS103HP's safety and ability to improve postoperative joint function and reduce pain following arthroscopic surgery.

The Phase 1 randomized, double-blind, vehicle-controlled and parallel-assigned study of OMS201 is designed to evaluate the systemic absorption and safety of OMS201 in patients receiving primary treatment by endoscopic removal of urinary stones. OMS201, developed from Omeros' proprietary PharmacoSurgery(TM) platform, is designed for use during urological surgery, including uroendoscopic procedures such as ureteroscopy, cystoscopy and minima
'/>"/>

SOURCE Omeros Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
2. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
3. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
4. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
5. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
6. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
9. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
10. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
11. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, ... Japan,s Ministry of Health, Labor ... Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe.   ... AQ -Flex™ 19 miniprobe is comprised of a ...
(Date:7/6/2015)... Calif. , July 6, 2015  Protiviti, a ... 2015 Internal Auditing around the World publication ... has analyzed and reported on the evolution of the ... from around the globe as a means to providing ... understanding of this strategic business function. The ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ... Grade Sodium Chloride Market by Applications, by Region - ... their offering. The pharmaceutical grade sodium chloride ... between 2014 and 2019 in terms of volume, and ... 2019. The report on Pharmaceutical grade sodium ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... and LONDON, April 14 Rib-X,Pharmaceuticals, Inc. ("Rib-X" ... discovery and development of novel antibiotics for,the treatment ... of the Medical Research Council (MRC) today announced,they ... area of,ribosome and antibiotic structure and function for ...
... who,purchased raw milk from Beulah Land Jerseys in ... it immediately due to the risk of,Listeria Monocytogenes ... milk is milk that has not been pasteurized ... permitted and have samples of,their milk laboratory tested ...
Cached Medicine Technology:Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council 2
(Date:7/6/2015)... ... 06, 2015 , ... Understanding the new ICD-10 requirements is ... the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the ... The ten tips are timely and relevant guidelines to help radiology practices avoid ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health ... other serious medical conditions. Screenings are affordable and accurate and run about an ...
(Date:7/6/2015)... ... July 06, 2015 , ... Seedstock today announced Pierre Sleiman, founder and ... 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to ... the University of California-San Diego, will explore solutions and methodologies that small farmers and ...
(Date:7/6/2015)... ... 06, 2015 , ... With a new community program in ... with Family Emergency Shelter Coalition (FESCO) and announced a new charity campaign to ... to provide emergency services and support for homeless families, all the while moving ...
(Date:7/6/2015)... ... 06, 2015 , ... In a split second, breaking a bone can cause ... having a fracture through the bone health screenings conducted by American Bone Health trained ... because our residents need this information to remain independent and strong for many more ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2
... 8, 2008 Optimal Readings,Services Group, Inc., a ... radiology groups, announced today that Rita Edwards has,been ... the recent acquisition of two radiology groups (National,Radiology ... provides,radiology services for more than 115 hospitals," said ...
... lung cancer (SCLC) patients treated with high-dose chemotherapy did ... standard doses, according to a randomized controlled trial published ... National Cancer Institute . , SCLC accounts for nearly ... States. Although many patients with SCLC initially respond to ...
... ports and shipping regions may be markedly worse than ... industrial and shipping pollution is exacerbated when it combines ... paper published in this weeks advance online edition of ... included University of Calgary chemistry professor Hans Osthoff report ...
... DUBLIN, Ohio, April 8, 2008 Cardinal Health,Inc. (NYSE: ... that improve,the safety and productivity of health care, plans to ... to the opening of trading,on the New York Stock Exchange., ... for May 1 at,8:30 a.m. EDT to discuss results of ...
... Survival time rose with combo therapy for advanced disease, ... By combining a special type of chemotherapy (TACE) with ... the survival of people with advanced liver cancer by ... either treatment alone. , "Our study demonstrates that combination ...
... drugs by women during their childbearing years and there ... alone or in combination with other drugs, may have ... evidence that THC, the main psychoactive component of marijuana, ... intrauterine growth retardation and that infants exposed to marijuana ...
Cached Medicine News:Health News:Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations 2Health News:High-intensity chemotherapy does not improve survival in small cell lung cancer 2Health News:Sea salt worsens coastal air pollution: study 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 3Health News:Two Liver Cancer Treatments Better Than One 2Health News:Two Liver Cancer Treatments Better Than One 3Health News:Marijuana increases alcohol toxicity in young rats 2
... to quality patient care., ,S/5 Anesthesia ... to anesthesia delivery. As part of the ... features, electronically controlled gas delivery and agent ... to create a truly integrated system. The ...
... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
... SS is a complete physician preference card ... management system for all the supply management ... preference card system combined with a broad ... entire case cart and operating suite supply ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
Medicine Products: